Skip to content

Clinical trials

Phase 3 Endometrial Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 3 Country / region: France Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20091
20161
20171
20181
20212
20222
20231
20242
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Active, not recruiting6
Completed6
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Merck Sharp & Dohme LLC3
AstraZeneca2
Leiden University Medical Center2
ARCAGY/ GINECO GROUP1
BioNTech SE1
Daiichi Sankyo1
Eisai Inc.1
Genmab1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms21
Uterine Cervical Neoplasms3
Head and Neck Neoplasms2
Melanoma2
Neoplasm Metastasis2
Neoplasms2
Ovarian Neoplasms2
Sarcoma2
Sarcoma, Endometrial Stromal2
Uterine Neoplasms2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.